Early research (Phase 1)Study completedNCT05286567
What this trial is testing
Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.
Who this might be right for
Hidradenitis Suppurativa
Aarhus University Hospital 15